Product Code: ETC9975811 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sarcopenia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sarcopenia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sarcopenia Market - Industry Life Cycle |
3.4 United States (US) Sarcopenia Market - Porter's Five Forces |
3.5 United States (US) Sarcopenia Market Revenues & Volume Share, By Supplement Type, 2021 & 2031F |
3.6 United States (US) Sarcopenia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Sarcopenia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the United States |
4.2.2 Growing awareness about the impact of sarcopenia on overall health |
4.2.3 Rising adoption of preventive healthcare measures |
4.2.4 Technological advancements in diagnostic tools for sarcopenia |
4.3 Market Restraints |
4.3.1 Limited availability of specific treatment options for sarcopenia |
4.3.2 Lack of standardized diagnostic criteria for sarcopenia |
4.3.3 High cost associated with diagnostic tests and treatment for sarcopenia |
4.3.4 Limited reimbursement policies for sarcopenia-related care |
5 United States (US) Sarcopenia Market Trends |
6 United States (US) Sarcopenia Market, By Types |
6.1 United States (US) Sarcopenia Market, By Supplement Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sarcopenia Market Revenues & Volume, By Supplement Type, 2021- 2031F |
6.1.3 United States (US) Sarcopenia Market Revenues & Volume, By Protein Supplement, 2021- 2031F |
6.1.4 United States (US) Sarcopenia Market Revenues & Volume, By Vitamin D & Calcium Supplement, 2021- 2031F |
6.1.5 United States (US) Sarcopenia Market Revenues & Volume, By Vitamin B12 Supplement, 2021- 2031F |
6.2 United States (US) Sarcopenia Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sarcopenia Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 United States (US) Sarcopenia Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 United States (US) Sarcopenia Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 United States (US) Sarcopenia Market Revenues & Volume, By Hypermarket & Supermarket, 2021- 2031F |
7 United States (US) Sarcopenia Market Import-Export Trade Statistics |
7.1 United States (US) Sarcopenia Market Export to Major Countries |
7.2 United States (US) Sarcopenia Market Imports from Major Countries |
8 United States (US) Sarcopenia Market Key Performance Indicators |
8.1 Average time to diagnose sarcopenia in the US population |
8.2 Percentage increase in research funding for sarcopenia-related studies |
8.3 Adoption rate of new diagnostic tools for sarcopenia |
8.4 Number of educational campaigns on sarcopenia awareness |
8.5 Percentage of healthcare providers trained in sarcopenia management and treatment |
9 United States (US) Sarcopenia Market - Opportunity Assessment |
9.1 United States (US) Sarcopenia Market Opportunity Assessment, By Supplement Type, 2021 & 2031F |
9.2 United States (US) Sarcopenia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Sarcopenia Market - Competitive Landscape |
10.1 United States (US) Sarcopenia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sarcopenia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |